Root Admin Guide Posted September 11, 2017 Root Admin Report Share Posted September 11, 2017 "LAUSANNE, Switzerland, Sept. 11, 2017 /PRNewswire/ -- Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published in the Journal of Drugs in Dermatology." Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study, PRNewswire, MarketsInsider, BusinessInsider Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now